The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of PTEN loss with outcome of patients (pts) with early high-risk prostate cancer (CaP) treated with adjuvant docetaxel following radical prostatectomy (RP).
Daniel Keizman
No relevant relationships to disclose
Zhe Zhang
No relevant relationships to disclose
Angelo DeMarzo
No relevant relationships to disclose
Bora Gurel
No relevant relationships to disclose
Tamara Lotan
No relevant relationships to disclose
Jessica Hicks
No relevant relationships to disclose
Eli Rosenbaum
No relevant relationships to disclose
Emmanuel S. Antonarakis
No relevant relationships to disclose
Michael Anthony Carducci
No relevant relationships to disclose
Mario A. Eisenberger
No relevant relationships to disclose